TG Therapeutics
TGTX
TGTX
127 hedge funds and large institutions have $267M invested in TG Therapeutics in 2018 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 46 increasing their positions, 30 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
19% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 27
50% less capital invested
Capital invested by funds: $534M → $267M (-$267M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
127
Holding in Top 10
–
Calls
$9.97M
Puts
$11.8M
Top Buyers
| 1 | +$21.9M | |
| 2 | +$10.9M | |
| 3 | +$7.36M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.14M |
| 5 |
6CM
683 Capital Management
New York
|
+$2.8M |
Top Sellers
| 1 | -$4.76M | |
| 2 | -$4.2M | |
| 3 | -$4.15M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.48M |
| 5 |
CCI
Columbus Circle Investors
|
-$2.83M |